3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
2
Leukemia, Plasma Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
ziprasidone
1
tocilizumab
1
talquetamab
1
idecabtagene vicleucel
1
golimumab
1
gilteritinib
1
anifrolumab
1
Zolpidem
1
X-Rays
1
Wearable Electronic Devices
1
Watchful Waiting
1
Warfarin
1
Vital Signs
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factor Inhibitors
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Rituximab
1
Procalcitonin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Infections
×
talquetamab
×
Clear all
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled